Scientist.com Partners with Allele Biotech to Discover and Develop Therapeutic Nanoantibodies

Dec. 3, 2018 12:55 UTC

Allele uses experts from Scientist.com’s Genius Consulting NetworkTM and proprietary internal technology to create innovative biologics programs

SAN DIEGO--(BUSINESS WIRE)-- Scientist.com, the world's leading marketplace for outsourced scientific services, and Allele Biotechnology & Pharmaceuticals Inc., a leading San Diego-based preclinical-stage biopharmaceutical company, have partnered to develop nanoantibodies for therapeutic applications. Experts selected through Scientist.com’s Genius Consulting NetworkTM will assist Allele in applying its proprietary nanoantibody technology to multiple therapeutic areas.

“Allele Biotech has developed novel cutting-edge nanoantibody technologies with considerable therapeutic potential,” stated Kevin Lustig, PhD, Scientist.com’s CEO and Founder. “This partnership enables Allele to focus on exploring therapeutic applications of its proprietary nanoantibody candidates.”

Allele’s nanoantibodies are recombinant, fully humanized, camelid single-domain heavy-chain only (VHH) antibodies that can be linked together to produce multivalent new molecular entities. With their unique structure, small size, and ability to bind multiple targets with one construct, nanoantibodies are ideal for generating novel biologics.

“Scientist.com makes it easy for us to connect with industry-leading experts in drug discovery and development,” stated Dr. Jiwu Wang, CEO of Allele Biotech. “We use the marketplace to find the experts and services we need for our internal R&D programs.”

Scientist.com’s recently launched Genius Consulting Network offers access to world-class experts in pre-clinical and clinical research, IND-enabling programs, translational research, CMC services, NDA submission and commercial assessments, among other areas.

About Scientist.com

Scientist.com is the world's leading marketplace for outsourced research. The marketplace simplifies the entire research sourcing process, saving time and money and providing access to the latest innovative tools and technologies while maintaining full compliance with an organization’s procurement policies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised more than $33 million from Leerink Transformation Partners, 5AM Ventures, Heritage Provider Network, Bootstrap Ventures and Hollywood producer Jack Giarraputo among others. Visit scientist.com to learn more.

Join Scientist.com on social media: YouTube, LinkedIn, Twitter, Facebook and Instagram.

About Allele Biotechnology & Pharmaceuticals Inc.

Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that builds unique platforms based on cutting-edge science to generate disruptive therapies. Allele uses proprietary technology for discovery and production of single domain nanoantibodies for highly valuable and diversified targets through its own powerful workflow established over the past 9 years. To date, Allele has generated recombinant nanoantibodies against over 20 different biomedically important antigens in the fields of inflammatory diseases, cancer, and cardiovascular diseases, among others. Allele is moving a number of programs supported by in vivo data through pre-clinical stages.

 

Contacts

Scientist.com
Sean Preci
Director of Communications
+1 858-455-1300, ext. 401
marketing@scientist.com

Allelebiotech.com
Carole Zeleny
Investor Relations
+1 858-410-0299
czeleny@allelebiotech.com

 

 
 

Source: Scientist.com

Back to news